Suppr超能文献

食物过敏儿童口服免疫疗法长期脱敏的预测因素:一项真实世界队列研究。

Predictors of Long-Term Desensitization in Children Treated with Oral Immunotherapy for Food Allergy: A Real-World Cohort Study.

作者信息

Hoshi-Funakawa Miyuki, Nagao Mizuho, Kawamoto Norio, Ohnishi Hidenori, Fujisawa Takao

机构信息

Allergy Center, NHO Mie National Hospital, Tsu 514-0125, Japan.

Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

出版信息

J Clin Med. 2025 Jul 3;14(13):4727. doi: 10.3390/jcm14134727.

Abstract

: The degree of desensitization achieved through oral immunotherapy (OIT) varies widely. This study aimed to identify factors predictive of full desensitization-defined as daily, symptom-free consumption of allergenic foods-in children with food allergies under real-world conditions. : A follow-up survey was conducted for all children who received OIT at Mie National Hospital, Japan, between 2008 and 2017, to assess long-term safety. Patients treated for hen's egg, cow's milk, or wheat allergy with at least five years of follow-up were included in the analysis. Data were collected from surveys and medical records, including treatment-emergent adverse events (TEAEs), baseline allergen-specific IgE (sIgE), and daily intake of allergenic foods. TEAEs were evaluated using the World Allergy Organization grading system. Full desensitization was defined as the ability to consume a typical daily portion of allergenic food without symptoms. Predictive factors were identified by multivariate logistic regression. : A total of 111 patients (142 OIT courses: egg = 72, milk = 47, wheat = 23) met inclusion criteria. The median age at OIT initiation was 6 years (IQR: 5-8). No TEAEs of grade 4 or grade 5 were reported. Overall, 30% of them achieved full desensitization: 32% in the egg group, 24% in the milk group, and 39% in the wheat group. Low baseline sIgE and absence of mild oral symptoms during build-up were identified as significant predictors. : Mild oral symptoms may signal lower likelihood of success. Monitoring them may support individualized OIT.

摘要

通过口服免疫疗法(OIT)实现的脱敏程度差异很大。本研究旨在确定在现实世界条件下,预测食物过敏儿童完全脱敏(定义为每日无症状食用致敏食物)的因素。

对2008年至2017年期间在日本三重国立医院接受OIT的所有儿童进行了随访调查,以评估长期安全性。分析纳入了接受鸡蛋、牛奶或小麦过敏治疗且随访至少五年的患者。从调查和医疗记录中收集数据,包括治疗中出现的不良事件(TEAE)、基线过敏原特异性IgE(sIgE)以及致敏食物的每日摄入量。使用世界过敏组织分级系统评估TEAE。完全脱敏定义为能够食用典型的每日致敏食物量且无症状。通过多变量逻辑回归确定预测因素。

共有111名患者(142个OIT疗程:鸡蛋=72,牛奶=47,小麦=23)符合纳入标准。开始OIT时的中位年龄为6岁(IQR:5-8)。未报告4级或5级TEAE。总体而言,其中30%实现了完全脱敏:鸡蛋组为32%,牛奶组为24%,小麦组为39%。低基线sIgE和在剂量递增期间无轻度口腔症状被确定为显著预测因素。

轻度口腔症状可能预示成功的可能性较低。对其进行监测可能有助于个性化OIT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5106/12251376/d92348f7a975/jcm-14-04727-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验